Literature DB >> 7357618

Fibroblast adhesion to fibrinogen and fibrin substrata: requirement for cold-insoluble globulin (plasma fibronectin).

F Grinnell, M Feld, D Minter.   

Abstract

We carried out experiments to determine conditions for fibroblast adhesion to fibrinogen and fibrin substrata. Baby hamster kidney (BHK) cells did not attach to substrata composed of purified fibrinogen or fibrin. When cold-insoluble globulin (CIG) (plasma fibronectin) was bound to fibrinogen or fibrin substrata, adhesion of BHK sells was observed and the extent of adhesion was dependent upon the CIG conecntration. Binding of CIG to fibrinogen or fibrin substrata in the presence of Factor XIII (factor) under covalent crosslinking conditions resulted in a marked increased in the ability of the substrata to support cell adhesion. Control experiments indicated that CIG formed the sites on the fibrinogen and fibrin substrata to which the cells were attaching. In addition, the effect of factor XIII was shown to require covalent crossliking of CIG to the fibrinogen or fibrin, which involved a glutamine residue on the CIG molecule and could be prevented by prior crosslinking of CIG with putrescine or with itself. The enhanced ability of Factor XIII-crosslinked CIG substrata to support cell adhesion could not be accounted for by the absolute amount of CIG bound to the substrata. We present in this paper the possibility that the orientation of CIG on the substrata is the critical factor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357618     DOI: 10.1016/0092-8674(80)90526-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  65 in total

1.  Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain.

Authors:  L A Bunce; L A Sporn; C W Francis
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

2.  Bacterial infection of wounds: fibronectin-mediated adherence group A and C streptococci to fibrin thrombi in vitro.

Authors:  G S Chhatwal; P Valentin-Weigand; K N Timmis
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Interaction of the fibronectin COOH-terminal Fib-2 regions with fibrin: further characterization and localization of the Fib-2-binding sites.

Authors:  Evgeny Makogonenko; Kenneth C Ingham; Leonid Medved
Journal:  Biochemistry       Date:  2007-04-11       Impact factor: 3.162

4.  Intra-alveolar fibrosis of idiopathic bronchiolitis obliterans-organizing pneumonia. Cell-matrix patterns.

Authors:  S Peyrol; J F Cordier; J A Grimaud
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

5.  Critical role of factor XIII in the initial stages of carbon tetrachloride-induced adult liver remodeling.

Authors:  Ikuko Tsujimoto; Kei Moriya; Keiko Sakai; Gerhard Dickneite; Takao Sakai
Journal:  Am J Pathol       Date:  2011-10-19       Impact factor: 4.307

6.  Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity.

Authors:  Y V Matsuka; S Pillai; S Gubba; J M Musser; S B Olmsted
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Extracellular matrices in peritendinous connective tissue after surgical injury to the chicken flexor tendon.

Authors:  K Hiranuma; K Suzuki; K Hirata; H Nakamura; K Higashi; H Hirano
Journal:  Arch Orthop Trauma Surg       Date:  1996       Impact factor: 3.067

8.  Binding of matrix metalloproteinase 9 to fibrin is mediated by amorphous calcium-phosphate.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

Review 9.  Fibronectin and the critically ill patient: current status.

Authors:  T M Saba; J L Kiener; J M Holman
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

10.  Effects of fibrin-binding oligopeptide on osteopromotion in rabbit calvarial defects.

Authors:  Ju-A Lee; Young Ku; In-Chul Rhyu; Chong-Pyoung Chung; Yoon-Jeong Park
Journal:  J Periodontal Implant Sci       Date:  2010-10-31       Impact factor: 2.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.